NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• NOTCH1 is a key oncogenic driver in T-lymphoblastic leukemia, regulating gene expression through transcription complexes.
• Gamma-secretase inhibitors block NOTCH1 nuclear localization but affect only a subset of NOTCH1-regulated genes.

Purpose of the Study:

• To identify and characterize the functional NOTCH1 binding sites in T-lymphoblastic leukemia.
• To understand how NOTCH1 regulates gene expression, particularly in relation to enhancers and chromatin structure.

Main Methods:

• Chromatin immunoprecipitation followed by sequencing (ChIP-seq) to map NOTCH1 binding sites.
• Analysis of gene expression changes in response to gamma-secretase inhibitor treatment.
• Integration of genomic data to identify co-occupancy with other transcription factors and chromatin modifiers.

Main Results:

• Fewer than 10% of NOTCH1 binding sites exhibit dynamic changes upon NOTCH1 inhibition.
• Dynamic NOTCH1 sites are primarily located in distal enhancers, often co-occupied by RUNX1, and regulate genes like IL7R.
• The majority of dynamic NOTCH1 sites reside within superenhancers, where NOTCH1 occupancy changes correlate with alterations in H3K27ac levels and gene expression.

Conclusions:

• Functional NOTCH1 regulation in T-lymphoblastic leukemia is primarily mediated by dynamic binding at specific enhancer regions, particularly superenhancers.
• NOTCH1 directly influences superenhancer activity, impacting target gene expression in T-lymphoblastic leukemia.
• This study provides a framework for identifying functionally relevant NOTCH1 binding sites genome-wide.